Mphasis

Mphasis Financial Leverage

The Financial Leverage (Equity Multiplier) of Mphasis (MPHASIS.NS) as of Sep 20, 2026 is 1.66. In the previous year, Financial Leverage (Equity Multiplier) was 1.55 — a change of 6.91% (higher).

Financial Leverage

1.66

YoY

6.91%

Last updated:

Financial Leverage (Equity Multiplier) of Mphasis is 2026 1.66 . Financial Leverage (Equity Multiplier) of Mphasis was 2025 1.55 . It decreases by 6.91% higher compared to the previous year.

The Mphasis Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2019
1.40 INR
Jan 1, 2020
1.50 INR
Jan 1, 2021
1.44 INR
Jan 1, 2022
1.55 INR
Jan 1, 2023
1.46 INR
Jan 1, 2024
1.61 INR
Jan 1, 2025
1.55 INR
Jan 1, 2026
1.66 INR
The Mphasis Financial Leverage history
YEARFinancial LeverageYoY
1.66+6.91%
1.55-3.64%
1.61+9.81%
1.46-5.56%
1.55+7.58%
1.44-4.09%
1.50+6.94%
1.40+10.18%
1.27+7.15%
1.19-6.11%
1.27-6.41%
1.35-0.96%
1.37
Access this data via the Eulerpool API

Mphasis Stock analysis

What does Mphasis do? Mphasis Ltd is a global IT company founded in India in 1992. It specializes in providing digital solutions and services to help businesses optimize and automate their processes. The company is divided into various divisions, each focused on specific IT services and products. These divisions include Banking & Capital Markets, Insurance, Communications, as well as Life Sciences and Healthcare. In the Banking & Capital Markets division, Mphasis Ltd offers solutions for customers in the finance sector, such as digital transformation of banks and the integration of payment and banking apps. The Insurance division focuses on optimizing processes within the insurance industry, providing solutions that help consolidate and automate business processes for insurance companies. The Communications division specializes in supporting companies in the digital communication field, offering services like integrating voice, data, and video applications. In the Life Sciences and Healthcare division, the company focuses on developing medical applications and implementing IT solutions in the healthcare industry, including the development of IoT systems for medical devices and the establishment of cloud-based patient databases. In addition to these divisions, Mphasis Ltd also offers other products and solutions that can be used independently of the specific divisions. These include digital ecosystems to connect and optimize business processes, as well as services in the area of data privacy and cybersecurity. Mphasis Ltd's business model is based on digital solutions and services that help improve businesses. The company focuses on the individual requirements of its customers and offers customized solutions, using advanced technologies like cloud computing, artificial intelligence, and machine learning. Overall, Mphasis Ltd has developed a wide range of solutions and products tailored to the individual needs of its customers. The company embraces innovative thinking and the use of cutting-edge technologies to provide added value to its customers and drive their business forward. Mphasis is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Mphasis stock

Financial Leverage (Equity Multiplier) of Mphasis is 1.66 in 2026.

Financial Leverage (Equity Multiplier) of Mphasis changed from 1.55 to 1.66, representing a 6.91% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Mphasis since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Mphasis with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Mphasis

All Key Metrics — Mphasis